BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Madrigal to Present New Data from the Company’s MASH Program at AASLD’s The Liver Meeting 2025

  October 29, 2025

   · 

  12 min read
• Press Releases

  ORYZON Strengthens Regulatory Strategy with the Appointment of Dr. Iman Barilero as Senior Advisor for Regulatory Affairs

  October 29, 2025

   · 

  7 min read
• Press Releases

  STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements

  October 29, 2025

   · 

  7 min read
• Press Releases

  Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

  October 29, 2025

   · 

  8 min read
• Press Releases

  CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley

  October 29, 2025

   · 

  5 min read
• Press Releases

  Kestra Medical Technologies to Present at the Stifel 2025 Healthcare Conference

  October 29, 2025

   · 

  1 min read
• Press Releases

  Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee

  October 29, 2025

   · 

  12 min read
• Press Releases

  Cidara Therapeutics to Participate in November 2025 Investor Conferences

  October 29, 2025

   · 

  1 min read
• Press Releases

  Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4

  October 29, 2025

   · 

  1 min read
• Press Releases

  Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025

  October 29, 2025

   · 

  1 min read